Home/Filings/4/0001415889-24-023552
4//SEC Filing

Orwin John A 4

Accession 0001415889-24-023552

CIK 0001370053other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 6:45 PM ET

Size

7.4 KB

Accession

0001415889-24-023552

Insider Transaction Report

Form 4
Period: 2024-09-15
Orwin John A
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-15+1,3003,335 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-09-151,3002,600 total
    Common Stock (1,300 underlying)
Footnotes (2)
  • [F1]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001477384

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 6:45 PM ET
Size
7.4 KB